Vimarsana
Biggest News Aggregation in the World

Angina Pectoris News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Angina Pectoris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Angina Pectoris Today - Breaking & Trending Today

Ischemic Heart Disease (IHD) Drugs Market Worth USD 8.46 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. - Vimarsana News

Ischemic Heart Disease (IHD) Drugs Market Worth USD 8.46 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

JERSEY CITY, N.J., May 30, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Ischemic Heart Disease (IHD) Drugs Market- (By

In Angina, Gene Therapy Coaxes Heart Vessel Growth - Vimarsana News

In Angina, Gene Therapy Coaxes Heart Vessel Growth

The experimental new approach, delivered to the heart of those with angina after bypass surgery, showed evidence of restored blood flow 1 year later.

Which Emergencies Are Genuine Emergencies? - Vimarsana News

Which Emergencies Are Genuine Emergencies?

About half of patients in emergency rooms do not have a medical emergency, according to one clinician.

Coronary Sinus Reducer an Option for Intractable Angina? - Vimarsana News

Coronary Sinus Reducer an Option for Intractable Angina?

A coronary sinus reducer met one of two primary endpoints by reducing refractory angina in the ORBITA-COSMIC trial, but not the second, improvement in perfusion.

Chelation Therapy Provides No Benefit Post-MI - Vimarsana News

Chelation Therapy Provides No Benefit Post-MI

Chelation therapy to remove potentially toxic levels of lead was not associated with a reduction in CV events in post-MI patients with diabetes in the TACT2 trial.